miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression
about
MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate CancerLanguage-Agnostic Reproducible Data Analysis Using Literate Programming.MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma.A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.miR-539 inhibits prostate cancer progression by directly targeting SPAG5LAPTM4B: an oncogene in various solid tumors and its functions.miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma.Gene interference strategies as a new tool for the treatment of prostate cancer.Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy.Missing link between microRNA and prostate cancer.Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection.Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.Prediction of miRNA-disease Associations using an Evolutionary Tuned Latent Semantic Analysis.Association between LAPTM4B gene polymorphism and prostate cancer susceptibility in an Iranian population.The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.LAPTM4B-35 is a novel prognostic factor for glioblastoma.Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer.Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma.
P2860
Q26751983-84C21B94-0E12-4A06-B1F8-7CF1598E8046Q31135215-C10A7959-13CB-4833-9140-6EE627CF77F2Q36025254-21F5B9D0-032A-4421-A380-E346AE9BA0A3Q36212307-F14E0896-11D4-4ED0-83A0-72C22B6B1C67Q36758507-E7FDAD21-4BB5-43F2-A593-9A5448E7BC4BQ37510652-013E13B8-FE4D-44CF-BE45-902CE9152E9FQ37707562-04B0DEB5-34A4-4F5E-9B9E-DE3BC6BB4935Q38518046-79A0B662-E52F-447B-AC1C-7C9A315BD46EQ38661848-AC623308-B2CC-48E2-8B07-708B5419E55BQ38715316-0C8A231D-B798-4CF1-9A44-F198A755784BQ38798431-241525D0-1D0F-4476-8E99-07358DC66AD2Q38826028-093B75DD-4790-4057-ABFF-85758BE5A759Q39416069-745D0BCD-777E-4550-8366-D17D2615925CQ40128942-EC43E7B0-18E7-4F15-A1A3-C8FBA229B76DQ40147257-5FC78D6E-49DD-4B8B-B741-8A3C00A93F96Q41621167-2DA0FF0F-C45F-4FC6-BCAB-454D8212E7B9Q42351255-B068E3B1-1E62-4D3B-BBC7-A2A89DF284BAQ47669687-418C3FC8-3FA0-4D9C-A0B1-ECCA2C6C5F88Q48342411-6EB9FC21-0807-4D66-8ABA-3D33999C7F8FQ52691481-AA2D0FA3-9DC1-4E7C-A22F-2F666385DDA4Q54962236-D67758C7-D9AA-4FE9-8590-04CCCB482049
P2860
miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
miR-188-5p inhibits tumour gro ...... repressing LAPTM4B expression
@ast
miR-188-5p inhibits tumour gro ...... repressing LAPTM4B expression
@en
type
label
miR-188-5p inhibits tumour gro ...... repressing LAPTM4B expression
@ast
miR-188-5p inhibits tumour gro ...... repressing LAPTM4B expression
@en
prefLabel
miR-188-5p inhibits tumour gro ...... repressing LAPTM4B expression
@ast
miR-188-5p inhibits tumour gro ...... repressing LAPTM4B expression
@en
P2093
P2860
P356
P1433
P1476
miR-188-5p inhibits tumour gro ...... repressing LAPTM4B expression
@en
P2093
Hongtuan Zhang
Shiyong Qi
Yuzhuo Wang
P2860
P304
P356
10.18632/ONCOTARGET.3341
P407
P577
2015-03-01T00:00:00Z